Industry Coalition Supports Continued Efforts to Oppose Waiver Proposal

Published date30 March 2021
Subject MatterTrade Secrets,WTO,Life Sciences,Copyright,Biotechnology,Biosimilars,Industrial Design,Intellectual Property Protection,Pharmaceutical Industry,Coronavirus/COVID-19,Biden Administration
AuthorDonald Zuhn
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT